1072269-82-9

Upstream product

• 339016-18-1 4-chloro-6-(4-morpholinyl)-2-pyrimidinamine 
• 1072084-70-8 4-chloro-6-morpholin-4-yl-pyrimidine-2-carboxylic acid methyl ester 
• 1072269-60-3 (4-chloro-6-morpholin-4-yl-pyrimidin-2-yl)-methanol 
• 1072084-69-5 4-chloro-6-morpholinopyrimidine-2-carbonitrile 
• 1072084-73-1 4-(6-chloro-2-iodopyrimidin-4-yl)morpholine 
• 1072269-62-5 4-(2-bromomethyl-6-chloro-pyrimidin-4-yl)-morpholine 
• 64-04-0 phenethylamine 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOUNDS

The invention provides a compound which is a pyrimidine of formula (I): The compounds are inhibitors of PI3K and may thus be used to treat diseases and disorders arising from abnormal cell growth, function or behaviour associated with PI3 kinase such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.